Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents

NCT01249001 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped lack of eligible participants to enrol

Conditions

Nausea
Vomiting
Chemotherapy

Interventions

DRUG: Oral Aprepitant
DRUG: Aprepitant

Sponsor

The Hospital for Sick Children